Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Lucas Michon"'
Autor:
Jean-Philippe Foy, Andy Karabajakian, Sandra Ortiz-Cuaran, Maxime Boussageon, Lucas Michon, Jebrane Bouaoud, Dorssafe Fekiri, Marie Robert, Kim-Arthur Baffert, Geneviève Hervé, Pauline Quilhot, Valéry Attignon, Angélique Girod, André Chaine, Mourad Benassarou, Philippe Zrounba, Christophe Caux, François Ghiringhelli, Sylvie Lantuejoul, Carole Crozes, Isabelle Brochériou, Maurice Pérol, Jérôme Fayette, Chloé Bertolus, Pierre Saintigny
Publikováno v:
Data in Brief, Vol 44, Iss , Pp 108556- (2022)
Identification of tumors harboring an overall active immune phenotype may help for selecting patients with advanced head and neck squamous cell carcinomas (HNSCC) and non-small cell lung cancer (NSCLC) who may benefit from immunotherapies. In this co
Externí odkaz:
https://doaj.org/article/dc4e546ef4f94d60bcf8550d81ded5eb
Autor:
Barak Rotblat, Andreas Mock, Jerome Fayette, Limor Cohen, Idan Cohen, Elena Voronov, Jebrane Bouaoud, Lucas Michon, Pierre Saintigny, Luc G T Morris, Manu Prasad, Jonathan Zorea, Sankar Jagadeeshan, Avital B Shnerb, Sooraj Mathukkada, Ofra Novoplansky, Mai Badarni, Ksenia M Yegodayev, Sapir Tzadok, Libor Brezina, Andy Karabajakian, Tomer Cooks, Irit Allon, Orr Dimitstein, Benzion Joshua, Dexin Kong, Maurizio Scaltriti, Yaron Carmi, Cristina Conde-Lopez, Jochen Hess, Ina Kurth, Moshe Elkabets
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 3 (2022)
Background Although the mitogen-activated protein kinases (MAPK) pathway is hyperactive in head and neck cancer (HNC), inhibition of MEK1/2 in HNC patients has not shown clinically meaningful activity. Therefore, we aimed to characterize the effect o
Externí odkaz:
https://doaj.org/article/e52b0f83da384bc987314eeb1cc6f2e4
Autor:
Auriole Tamegnon, Mei Jiang, Jebrane Bouaoud, Frank Rojas Alvarez, Lucas Michon, Nicolas Gadot, Sylvie Lantuejoul, Shanyu Zhang, Pandurengan Renganayaki, Philippe Zrounba, Jean-Philippe Foy, Karène Mahtouk, Chloé Bertolus, Edwin Roger Parra Cuentas, Pierre Saintigny
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/16d92198f7c649fd94048b05d888639c
Autor:
Auriole Tamegnon, Mei Jiang, Edwin Parra, Frank Rojas, Jebrane Bouaoud, Lucas Michon, Nicolas Gadot, Sylvie Lantuejoul, Shanyu Zhang, Pandurengan Renganayaki, Philippe Zrounba, Jean-Philippe Foy, Karène Mahtouk, Chloé Bertolus, Pierre Saintigny
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/909a63ad604445ceb22e8829e8676a31
Autor:
Jebrane Bouaoud, Jean-Philippe Foy, Antonin Tortereau, Lucas Michon, Vincent Lavergne, Nicolas Gadot, Sandrine Boyault, Julie Valantin, Geneviève De Souza, Philippe Zrounba, Chloé Bertolus, Nathalie Bendriss-Vermare, Pierre Saintigny
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Understanding the dynamics of the immune microenvironment is critical to the development of immuno-based strategies for the prevention of oral potentially malignant disorders transformation to oral squamous cell carcinoma (OSCC). We used laser captur
Externí odkaz:
https://doaj.org/article/a3fb5b680a9e4f0ea45c23935f4e9ad5
Autor:
Jean-Philippe Foy, Andy Karabajakian, Sandra Ortiz-Cuaran, Maxime Boussageon, Lucas Michon, Jebrane Bouaoud, Dorssafe Fekiri, Marie Robert, Kim-Arthur Baffert, Geneviève Hervé, Pauline Quilhot, Valéry Attignon, Angélique Girod, André Chaine, Mourad Benassarou, Philippe Zrounba, Christophe Caux, François Ghiringhelli, Sylvie Lantuejoul, Carole Crozes, Isabelle Brochériou, Maurice Pérol, Jérôme Fayette, Chloé Bertolus, Pierre Saintigny
Publikováno v:
European Journal of Cancer. 174:287-298
Identification of tumours harbouring an overall active immune phenotype may help for selecting patients with advanced head and neck squamous cell carcinomas (HNSCC) and non-small cell lung cancer (NSCLC) who may benefit from immunotherapies. Our obje
Autor:
Sandra Ortiz-Cuaran, Aurélie Swalduz, Jean-Philippe Foy, Solène Marteau, Anne-Pierre Morel, Frédérique Fauvet, Geneviève De Souza, Lucas Michon, Maxime Boussageon, Nicolas Gadot, Marion Godefroy, Sophie Léon, Antonin Tortereau, Nour-El-Houda Mourksi, Camille Leonce, Marie Alexandra Albaret, Anushka Dongre, Béatrice Vanbervliet, Marie Robert, Laurie Tonon, Roxane M. Pommier, Véronique Hofman, Valéry Attignon, Sandrine Boyault, Carole Audoynaud, Jessie Auclair, Fanny Bouquet, Qing Wang, Christine Ménétrier-Caux, Maurice Pérol, Christophe Caux, Paul Hofman, Sylvie Lantuejoul, Alain Puisieux, Pierre Saintigny
Publikováno v:
European Journal of Cancer. 169:106-122
Epithelial-to-mesenchymal transition (EMT) is associated with tumor aggressiveness, drug resistance, and poor survival in non-small cell lung cancer (NSCLC) and other cancers. The identification of immune-checkpoint ligands (ICPLs) associated with NS
Autor:
Aurelien Marabelle, Sylvie Chevret, Pierre Saintigny, Luis A. Diaz, Assia Lamrani-Ghaouti, Clotilde Simon, Frederic Legrand, Natalie Hoog-Labouret, Andrea Cercek, Neil H. Segal, Anthony Ferrari, Severine Tabone-Eglinger, Asha R. Krishnan, Guillem Argiles, Bill H. Diplas, Steven B. Maron, Michelle F. Lamendola-Essel, Dennis Stephens, Drew G. Gerber, Stephane Champiat, Jean-Charles Soria, Christophe Tournigand, Stephane Oudard, Farid El Hajbi, Diane Pannier, Thierry Andre, Olivier Bouche, Esma Saada-Bouzid, Sandrine Hiret, Frederic Rolland, Aude Flechon, Christelle de la Fouchardiere, Sophie Cousin, Muriel Duluc, Jean-Jacques Grob, Marielle Guillet, Amandine Bruyas, Rosine Guimbaud, Carlos Gomez-Roca, Damien Pouessel, Antoine Hollebecque, David Malka, Paule Augereau, Victor Simmet, Romain Cohen, Magali Svrcek, Julien Masliah-Planchon, Michael B. Foote, Valerie Attignon, Aurelien de Reynies, Lucas Michon, Nicolas Leulliot, Nadim Hamzaoui, Eric Pasmant, Ivan Bieche, Benoit Rousseau
Supplementary Figure from PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a68c6d0639646b5d1548ca8532028d21
https://doi.org/10.1158/2159-8290.22541047.v1
https://doi.org/10.1158/2159-8290.22541047.v1
Autor:
Aurelien Marabelle, Sylvie Chevret, Pierre Saintigny, Luis A. Diaz, Assia Lamrani-Ghaouti, Clotilde Simon, Frederic Legrand, Natalie Hoog-Labouret, Andrea Cercek, Neil H. Segal, Anthony Ferrari, Severine Tabone-Eglinger, Asha R. Krishnan, Guillem Argiles, Bill H. Diplas, Steven B. Maron, Michelle F. Lamendola-Essel, Dennis Stephens, Drew G. Gerber, Stephane Champiat, Jean-Charles Soria, Christophe Tournigand, Stephane Oudard, Farid El Hajbi, Diane Pannier, Thierry Andre, Olivier Bouche, Esma Saada-Bouzid, Sandrine Hiret, Frederic Rolland, Aude Flechon, Christelle de la Fouchardiere, Sophie Cousin, Muriel Duluc, Jean-Jacques Grob, Marielle Guillet, Amandine Bruyas, Rosine Guimbaud, Carlos Gomez-Roca, Damien Pouessel, Antoine Hollebecque, David Malka, Paule Augereau, Victor Simmet, Romain Cohen, Magali Svrcek, Julien Masliah-Planchon, Michael B. Foote, Valerie Attignon, Aurelien de Reynies, Lucas Michon, Nicolas Leulliot, Nadim Hamzaoui, Eric Pasmant, Ivan Bieche, Benoit Rousseau
Supplementary Data from PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15a66d609cc79fa4d01bedd59b08afcf
https://doi.org/10.1158/2159-8290.22541062
https://doi.org/10.1158/2159-8290.22541062
Autor:
Aurelien Marabelle, Sylvie Chevret, Pierre Saintigny, Luis A. Diaz, Assia Lamrani-Ghaouti, Clotilde Simon, Frederic Legrand, Natalie Hoog-Labouret, Andrea Cercek, Neil H. Segal, Anthony Ferrari, Severine Tabone-Eglinger, Asha R. Krishnan, Guillem Argiles, Bill H. Diplas, Steven B. Maron, Michelle F. Lamendola-Essel, Dennis Stephens, Drew G. Gerber, Stephane Champiat, Jean-Charles Soria, Christophe Tournigand, Stephane Oudard, Farid El Hajbi, Diane Pannier, Thierry Andre, Olivier Bouche, Esma Saada-Bouzid, Sandrine Hiret, Frederic Rolland, Aude Flechon, Christelle de la Fouchardiere, Sophie Cousin, Muriel Duluc, Jean-Jacques Grob, Marielle Guillet, Amandine Bruyas, Rosine Guimbaud, Carlos Gomez-Roca, Damien Pouessel, Antoine Hollebecque, David Malka, Paule Augereau, Victor Simmet, Romain Cohen, Magali Svrcek, Julien Masliah-Planchon, Michael B. Foote, Valerie Attignon, Aurelien de Reynies, Lucas Michon, Nicolas Leulliot, Nadim Hamzaoui, Eric Pasmant, Ivan Bieche, Benoit Rousseau
Missense mutations in the polymerase epsilon (POLE) gene have been reported to generate proofreading defects resulting in an ultramutated genome and to sensitize tumors to checkpoint blockade immunotherapy. However, many POLE-mutated tumors do not re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09a36140e69ccd60ecf121a937d16ebe
https://doi.org/10.1158/2159-8290.c.6549541
https://doi.org/10.1158/2159-8290.c.6549541